Merritt Gillilland

Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis

Yonghyun Lee, Kohei Sugihara, Merritt Gillilland et al. · Nature Materials · 2019 · 655 citations

Inflammation, Nanomedicine, Chronic Inflammatory Diseases +11

The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis

Sho Kitamoto, Hiroko Nagao‐Kitamoto, Yizu Jiao et al. · Cell · 2020 · 610 citations · Full text

Commensal Pathobiont-driven Colitis, Mucosal Immunology, Gastroenterology +7

Neonatal acquisition of <i>Clostridia</i> species protects against colonization by bacterial pathogens

Yun‐Gi Kim, Kei Sakamoto, Sang‐Uk Seo et al. · Science · 2017 · 292 citations · Full text

Dysbiosis, Pathogenic Microbiology, Microbial Pathogens +21

Functional Characterization of Inflammatory Bowel Disease–Associated Gut Dysbiosis in Gnotobiotic Mice

Hiroko Nagao‐Kitamoto, Andrew B. Shreiner, Merritt Gillilland et al. · Cellular and Molecular Gastroenterology and Hepatology · 2016 · 237 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Microbiota Function +12

Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota

Hiroko Nagao‐Kitamoto, Jhansi L. Leslie, Sho Kitamoto et al. · Nature Medicine · 2020 · 218 citations · Full text

Inflammation, Dysbiosis, Mucosal Immunology +12